Evidence map›Paper›PMID 34223097›Full record

ArticleJAC-antimicrobial resistance2021

Effects of flavophospholipol on conjugation and plasmid curing of multidrug-resistant

Kelvin Lim, Michael Pennell, Stephanie Lewis, Mohamed El-Gazzar, Wondwossen A Gebreyes

Open access · goldAbstract read
In one paragraph

Article in JAC-antimicrobial resistance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Kelvin LimVeterinary Health Management Branch, National Parks Board, 6 Perahu Road, Singapore 718827.ORCID https://orcid.org/0000-0002-9649-4302
Michael PennellDivision of Biostatistics, College of Public Health, The Ohio State University, 1841 Neil Ave, 246 Cunz Hall, Columbus, OH 43210, USA.
Stephanie LewisAnimal Resource Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA.
Mohamed El-GazzarDepartment of Veterinary Diagnostic and Production Animal Medicine, Iowa State University, 2203 Lloyd Veterinary Medical Centre, Ames, IA 50011, USA.
Wondwossen A GebreyesDepartment of Veterinary Preventive Medicine, College of Veterinary Medicine, The Ohio State University, A100R Sisson Hall, 1920 Coffey Rd, Columbus, OH 43210, USA.
The Ohio State University · USIowa State University · USNational Parks Board · SGThe University of Texas Southwestern Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly

objectivesThis 36-day controlled-challenge study aimed to evaluate the anti-conjugative and plasmid-curing effect of flavophospholipol

methodsA total of 270-day-old chicks were randomly assigned to four control and four treatment groups with two doses of in-feed flavophospholipol (10 ppm and 64 ppm) and in the presence and absence of ampicillin in drinking water. Chicks were orally challenged with

resultsFlavophospholipol given in-feed at 64 ppm had an anti-conjugative effect. There was a significant reduction of acquisition of resistance to ampicillin, streptomycin and tetracycline by the recipient strains of

conclusionsThe results demonstrate that flavophospholipol given in-feed at 64 ppm had an anti-conjugative effect. The results also suggest that AMR is reduced through other mechanisms of action, which are yet to be determined. There is insufficient evidence that flavophospholipol at 64 ppm in feed alone or with sub-therapeutic levels of antibiotics had a plasmid-curing effect.

Identifiers

PMID34223097
PMCPMC8210090
OpenAlexW3133509925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.